ALTO Fundamental Analysis - ALTO INGREDIENTS INC

Fundamental Rating

ALTO gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 85 industry peers in the Chemicals industry. ALTO may be in some trouble as it scores bad on both profitability and health. ALTO has a valuation in line with the averages, but it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year ALTO has reported negative net income.

In the past year ALTO has reported a negative cash flow from operations.

ALTO had negative earnings in 4 of the past 5 years.

Of the past 5 years ALTO 4 years had a positive operating cash flow.

1.2 Ratios

ALTO has a worse Return On Assets (-14.97%) than 78.82% of its industry peers.

ALTO has a Return On Equity of -28.14%. This is in the lower half of the industry: ALTO underperforms 74.12% of its industry peers.

		Industry Rank	Sector Rank
ROA	-14.97%
ROE	-28.14%
ROIC	N/A

ROA(3y)-10.14%

ROA(5y)-4.95%

ROE(3y)-17.06%

ROE(5y)-8.78%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 1.08%, ALTO is not doing good in the industry: 89.41% of the companies in the same industry are doing better.

ALTO's Gross Margin has declined in the last couple of years.

The Profit Margin and Operating Margin are not available for ALTO so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	1.08%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-43.6%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ALTO does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, ALTO has more shares outstanding

ALTO has more shares outstanding than it did 5 years ago.

The debt/assets ratio for ALTO is higher compared to a year ago.

2.2 Solvency

ALTO has an Altman-Z score of -0.09. This is a bad value and indicates that ALTO is not financially healthy and even has some risk of bankruptcy.

ALTO has a worse Altman-Z score (-0.09) than 83.53% of its industry peers.

A Debt/Equity ratio of 0.52 indicates that ALTO is somewhat dependend on debt financing.

Looking at the Debt to Equity ratio, with a value of 0.52, ALTO is in the better half of the industry, outperforming 64.71% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.52
Debt/FCF	N/A
Altman-Z	-0.09

ROIC/WACCN/A

WACC9.95%

2.3 Liquidity

A Current Ratio of 2.89 indicates that ALTO has no problem at all paying its short term obligations.

The Current ratio of ALTO (2.89) is better than 83.53% of its industry peers.

ALTO has a Quick Ratio of 1.94. This is a normal value and indicates that ALTO is financially healthy and should not expect problems in meeting its short term obligations.

With a decent Quick ratio value of 1.94, ALTO is doing good in the industry, outperforming 77.65% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	2.89
Quick Ratio	1.94

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

ALTO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -115.79%.

Looking at the last year, ALTO shows a very negative growth in Revenue. The Revenue has decreased by -17.26% in the last year.

The Revenue has been decreasing by -7.49% on average over the past years.

EPS 1Y (TTM)-115.79%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%5.88%

Revenue 1Y (TTM)-17.26%

Revenue growth 3Y-7.2%

Revenue growth 5Y-7.49%

Sales Q2Q%-5.87%

3.2 Future

The Earnings Per Share is expected to grow by 34.90% on average over the next years. This is a very strong growth

ALTO is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.23% yearly.

EPS Next Y59.45%

EPS Next 2Y46.96%

EPS Next 3Y34.9%

EPS Next 5YN/A

Revenue Next Year-2.41%

Revenue Next 2Y2.51%

Revenue Next 3Y12.23%

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALTO. In the last year negative earnings were reported.

With a Price/Forward Earnings ratio of 9.35, the valuation of ALTO can be described as very reasonable.

ALTO's Price/Forward Earnings ratio is rather cheap when compared to the industry. ALTO is cheaper than 82.35% of the companies in the same industry.

ALTO's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.90.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	9.35

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALTO is valued a bit more expensive than 76.47% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	28.66

4.3 Compensation for Growth

ALTO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

ALTO's earnings are expected to grow with 34.90% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y46.96%

EPS Next 3Y34.9%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

ALTO does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

ALTO INGREDIENTS INC

NASDAQ:ALTO (7/3/2025, 8:27:21 PM)

After market: 1.2498 +0.01 (+0.79%)

1.24

+0.01 (+0.81%)

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryChemicals

Earnings (Last)05-07 2025-05-07/amc

Earnings (Next)08-04 2025-08-04/amc

Inst Owners33.32%

Inst Owner Change-11.36%

Ins Owners4.64%

Ins Owner Change5.24%

Market Cap95.74M

Analysts82.5

Price Target4.08 (229.03%)

Short Float %1.22%

Short Ratio2.65

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly Dividend0.02

Dividend Growth(5Y)-2.34%

DP-2.1%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)-182.18%

Min EPS beat(2)-385.93%

Max EPS beat(2)21.57%

EPS beat(4)2

Avg EPS beat(4)-131.36%

Min EPS beat(4)-385.93%

Max EPS beat(4)50.98%

EPS beat(8)3

Avg EPS beat(8)-78.35%

EPS beat(12)4

Avg EPS beat(12)-1064.23%

EPS beat(16)5

Avg EPS beat(16)-813.08%

Revenue beat(2)1

Avg Revenue beat(2)2.01%

Min Revenue beat(2)-0.06%

Max Revenue beat(2)4.09%

Revenue beat(4)1

Avg Revenue beat(4)-1%

Min Revenue beat(4)-7.73%

Max Revenue beat(4)4.09%

Revenue beat(8)4

Avg Revenue beat(8)0.19%

Revenue beat(12)7

Avg Revenue beat(12)1.3%

Revenue beat(16)10

Avg Revenue beat(16)2.16%

PT rev (1m)-11.11%

PT rev (3m)-11.11%

EPS NQ rev (1m)0%

EPS NQ rev (3m)-16.67%

EPS NY rev (1m)8.33%

EPS NY rev (3m)-10%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)-4.69%

Revenue NY rev (1m)0%

Revenue NY rev (3m)-9.1%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	9.35
P/S	0.1
P/FCF	N/A
P/OCF	N/A
P/B	0.45
P/tB	0.47
EV/EBITDA	28.66

EPS(TTM)-0.82

EYN/A

EPS(NY)0.13

Fwd EY10.69%

FCF(TTM)-0.39

FCFYN/A

OCF(TTM)-0.3

OCFYN/A

SpS12.32

BVpS2.77

TBVpS2.67

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-14.97%
ROE	-28.14%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	1.08%
FCFM	N/A

ROA(3y)-10.14%

ROA(5y)-4.95%

ROE(3y)-17.06%

ROE(5y)-8.78%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-43.6%

GM growth 5YN/A

F-Score2

Asset Turnover2.36

Health

		Industry Rank	Sector Rank
Debt/Equity	0.52
Debt/FCF	N/A
Debt/EBITDA	17.66
Cap/Depr	27.88%
Cap/Sales	0.73%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	2.89
Quick Ratio	1.94
Altman-Z	-0.09

F-Score2

WACC9.95%

ROIC/WACCN/A

Cap/Depr(3y)107.88%

Cap/Depr(5y)83.14%

Cap/Sales(3y)2.13%

Cap/Sales(5y)1.7%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-115.79%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%5.88%

EPS Next Y59.45%

EPS Next 2Y46.96%

EPS Next 3Y34.9%

EPS Next 5YN/A

Revenue 1Y (TTM)-17.26%

Revenue growth 3Y-7.2%

Revenue growth 5Y-7.49%

Sales Q2Q%-5.87%

Revenue Next Year-2.41%

Revenue Next 2Y2.51%

Revenue Next 3Y12.23%

Revenue Next 5YN/A

EBIT growth 1Y-15.02%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year154.6%

EBIT Next 3Y64.22%

EBIT Next 5YN/A

FCF growth 1Y58.93%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y18.26%

OCF growth 3YN/A

OCF growth 5YN/A

ALTO INGREDIENTS INC (ALTO) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens